Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
0.98/2.36
|
|
Enterprise Value
4.57B
|
| Balance Sheet |
|
Book Value Per Share
-1.66
|
| Cash Flow |
|
Cash Flow Yield
0.04
|
| Income Statement |
|
Total Revenue
1.09B
|
|
Operating Revenue Per Share
8.01
|
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
|
Business Description
|
|||
| Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. |

34.58 
